Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shreyaskumar R Patel

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 26, 2007
Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapyB Ashleigh Guadagnolo, Gunar K Zagars, Matthew T Ballo, et al.
Neurosurgery|October 5, 2020
Computational Drug Repositioning Identifies Potentially Active Therapies for ChordomaJeffrey I Traylor, Hadley E Sheppard, Visweswaran Ravikumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
We should desist using RECIST, at least in GISTRobert S Benjamin, Haesun Choi, Homer A Macapinlac, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcomaMatthew T Ballo, Gunar K Zagars, Janice N Cormier, et al.
Cancer|May 7, 2003
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patientsGunar K Zagars, Matthew T Ballo, Peter W T Pisters, et al.
The Oncologist|August 8, 2018
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell ChondrosarcomaAnnemiek van Maldegem, Anthony P Conley, Piotr Rutkowski, et al.
Cancer|September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylateLucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteriaHaesun Choi, Chuslip Charnsangavej, Silvana C Faria, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapyB Ashleigh Guadagnolo, Gunar K Zagars, Matthew T Ballo, et al.
Cancer|September 11, 2019
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedinRobin L Jones, Robert G Maki, Shreyaskumar R Patel, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Radiation Oncology, Biology, Physics|September 26, 2007
Excellent local control rates and distinctive patterns of failure in myxoid liposarcoma treated with conservation surgery and radiotherapyB Ashleigh Guadagnolo, Gunar K Zagars, Matthew T Ballo, et al.
Neurosurgery|October 5, 2020
Computational Drug Repositioning Identifies Potentially Active Therapies for ChordomaJeffrey I Traylor, Hadley E Sheppard, Visweswaran Ravikumar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
We should desist using RECIST, at least in GISTRobert S Benjamin, Haesun Choi, Homer A Macapinlac, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcomaMatthew T Ballo, Gunar K Zagars, Janice N Cormier, et al.
Cancer|May 7, 2003
Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patientsGunar K Zagars, Matthew T Ballo, Peter W T Pisters, et al.
The Oncologist|August 8, 2018
Outcome of First-Line Systemic Treatment for Unresectable Conventional, Dedifferentiated, Mesenchymal, and Clear Cell ChondrosarcomaAnnemiek van Maldegem, Anthony P Conley, Piotr Rutkowski, et al.
Cancer|September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylateLucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteriaHaesun Choi, Chuslip Charnsangavej, Silvana C Faria, et al.
International Journal of Radiation Oncology, Biology, Physics|August 11, 2007
Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapyB Ashleigh Guadagnolo, Gunar K Zagars, Matthew T Ballo, et al.
Cancer|September 11, 2019
Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedinRobin L Jones, Robert G Maki, Shreyaskumar R Patel, et al.
Pageof 10